A molecular epidemiological analysis of 2 Staphylococcus aureus clonal types colonizing and infecting patients with AIDS

Clinical Infectious Diseases

Volumn 40, Issue 7, 2005, Pages 1028-1036

  Gordon, Rachel J ^a   Quagliarello, Bianca ^a   Cespedes, Christian ^a   Chung, Marilyn ^d   De Lencastre, Herminia ^d,h   Vavagiakis, Peter ^e   Miller, Maureen ^a,c   Zeller, Barbara ^f,g   Lowy, Franklin D ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Rockefeller University ^*  (United States)

^c Panna Technologies ^*  (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e Panna Technologies Inc   (United States)

^f Project Samaritan AIDS Services   (United States)

^g BRONX LEBANON HOSPITAL CENTER   (United States)

^h INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; RIFAMPICIN; STAPHYLOCOCCUS PROTEIN A;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HIGH RISK POPULATION; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NOSE; PHENOTYPE; PHYLOGENY; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 15744376483     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/428612     Document Type: Article

References (32)

1. Nguyen MH, Kauffman CA, Goodman RP, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999; 130:221-5.
2. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992; 11:985-9.
3. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34:425-33.
4. Petrosillo N, Viale P, Nicastri E, et al. Nosocomial bloodstream infections among human immunodeficiency virus - infected patients: incidence and risk factors. Clin Infect Dis 2002; 34:677-85.
5. Miller M, Cespedes C, Vavagiakis P, Klein RS, Lowy FD. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis 2003; 22:463-9.
6. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344:11-6.
7. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171:216-9.
8. Tuazon CU, Sheagren JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974; 129:725-7.
9. Quagliarello B, Cespedes C, Miller M, et al. Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis 2002; 35:671-7.
10. Cespedes C, Miller M, Quagliarello B, Vavagiakis P, Klein RS, Lowy FD. Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol 2002; 40:2594-7.
11. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J Clin Microbiol 2000; 38:3926-31.
12. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-15.
13. Crisostomo MI, Westh H, Tomasz A, Chung M, Oliveira DC, de Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci USA 2001; 98:9865-70.
14. Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37:3556-63.
15. Oliveira DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist 2001; 7:349-61.
16. NCCLS. Performance standards for antimicrobial disk susceptibility tests. 6th ed. NCCLS document M2-A6. Wayne, PA: NCCLS, 1997.
17. Ausubel FM, Brent R, Kingston RE, et al. Current protocols in molecular biology. Vol. 1, suppl. 25. Cambridge, United Kingdom: John Wiley and Sons, 1993.
18. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002; 46:1147-52.
19. Tomasz A, Nachman S, Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 1991; 35:124-9.
20. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:2155-61.
21. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99:7687-92.
22. Said-Salim B, Mathema B, Kreiswirth BN. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 2003; 24:451-5.
23. Roberts RB, Chung M, de Lencastre H, et al. Distribution of methicillin-resistant Staphylococcus aureus clones among health care facilities in Connecticut, New Jersey, and Pennsylvania. Tri-State MRSA Collaborative Study Group. Microb Drug Resist 2000; 6:245-51.
24. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison - Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:919-22.
25. Centers for Disease Control and Prevention. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. JAMA 2003; 289:1377.
26. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289-94.
27. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20.
28. Donnio PY, Louvet L, Preney L, Nicolas D, Avril JL, Desbordes L. Nine-year surveillance of methicillin-resistant Staphylococcus aureus in a hospital suggests instability of mecA DNA region in an epidemic strain. J Clin Microbiol 2002; 40:1048-52.
29. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002; 2:180-9.
30. Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. J Infect Dis 1999; 180:1809-18.
31. Edge MD, Rimland D. Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. AIDS 1996; 10:1635-9.
32. Wininger DA, Fass RJ. Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus - associated bacteremia. Antimicrob Agents Chemother 2002; 46:594-7.